Unveiling diagnostic and therapeutic strategies for cervical cancer: biomarker discovery through proteomics approaches and exploring the role of cervical cancer stem cells
Cervical cancer (CC) is a major global health problem and leading cause of cancer deaths among women worldwide. Early detection through screening programs has reduced mortality; however, screening compliance remains low. Identifying non-invasive biomarkers through proteomics for diagnosis and monito...
Saved in:
Published in | Frontiers in oncology Vol. 13; p. 1277772 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
24.01.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Cervical cancer (CC) is a major global health problem and leading cause of cancer deaths among women worldwide. Early detection through screening programs has reduced mortality; however, screening compliance remains low. Identifying non-invasive biomarkers through proteomics for diagnosis and monitoring response to treatment could improve patient outcomes. Here we review recent proteomics studies which have uncovered biomarkers and potential drug targets for CC. Additionally, we explore into the role of cervical cancer stem cells and their potential implications in driving CC progression and therapy resistance. Although challenges remain, proteomics has the potential to revolutionize the field of cervical cancer research and improve patient outcomes. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 Edited by: Marzieh Naseri, Tufts University, United States Jorge Olmos, Ensenada Center for Scientific Research and Higher Education (CICESE), Mexico Jeovanis Gil, Lund University, Sweden Reviewed by: Xiaoyuan Huang, Huazhong University of Science and Technology, China |
ISSN: | 2234-943X 2234-943X |
DOI: | 10.3389/fonc.2023.1277772 |